| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |